Cargando…
Insulin Secretion Capacity as a Crucial Feature to Distinguish Type 1 From Type 2 Diabetes and to Indicate the Need for Insulin Therapy – A Critical Discussion of the ADA/EASD Consensus Statement on the Management of Type 1 Diabetes in Adults
In the recently published consensus statement on the treatment and management of type 1 diabetes issued by experts from the American (ADA) and European (EASD) diabetes societies, measurement of endogenous insulin secretion using fasting C-peptide is recommended as a diagnostic criterion. In contrast...
Autor principal: | Fritsche, Andreas |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Georg Thieme Verlag KG
2023
|
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10581093/ https://www.ncbi.nlm.nih.gov/pubmed/37308105 http://dx.doi.org/10.1055/a-2016-8392 |
Ejemplares similares
-
The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021) -
Self-Mixed/Split Insulin Regimen: A Serious Omission in the ADA/EASD Position Statement
por: Davidson, Mayer B.
Publicado: (2014) -
Correction to: The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Holt, Richard I. G., et al.
Publicado: (2021) -
Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2018) -
Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)
por: Davies, Melanie J., et al.
Publicado: (2022)